Literature DB >> 9668098

Phorbol ester-induced transcription of a fibroblast growth factor-binding protein is modulated by a complex interplay of positive and negative regulatory promoter elements.

V K Harris1, E D Liaudet-Coopman, B J Boyle, A Wellstein, A T Riegel.   

Abstract

Earlier studies from our laboratory showed that a secreted binding protein for fibroblast growth factors (FGF-BP) is expressed at high levels in squamous cell carcinoma (SCC) cell lines. Overexpression studies or conversely reduced expression of FGF-BP by ribozyme targeting have elucidated a direct role of this protein in angiogenesis during tumor development. We have also observed a significant up-regulation of FGF-BP during TPA (12-O-tetradecanoylphorbol-13-acetate) promotion of skin cancer. Here we investigate the mechanism of TPA induction of FGF-BP gene expression in the human ME-180 SCC cell line. We found that TPA increased FGF-BP mRNA levels in a time- and dose-dependent manner mediated via the protein kinase C signal transduction pathway. Results from actinomycin D and cycloheximide experiments as well as nuclear transcription assays revealed that TPA up-regulated the steady-state levels of FGF-BP mRNA by increasing its rate of gene transcription independently of de novo protein synthesis. We isolated the human FGF-BP promoter and determined by deletion analysis that TPA regulatory elements were all contained in the first 118 base pairs upstream of the transcription start site. Further mutational analysis revealed that full TPA induction required interplay between several regulatory elements with homology to Ets, AP-1, and CAATT/enhancer binding protein C/EBP sites. In addition, deletion or mutation of a 10-base pair region juxtaposed to the AP-1 site dramatically increased TPA induced FGF-BP gene expression. This region represses the extent of the FGF-BP promoter response to TPA and contained sequences recognized by the family of E box helix-loop-helix transcription factors. Gel shift analysis showed specific and TPA-inducible protein binding to the Ets, AP-1, and C/EBP sites. Furthermore, distinct, specific, and TPA-inducible binding to the imperfect E box repressor element was also apparent. Overall, our data indicate that TPA effects on FGF-BP gene transcription are tightly controlled by a complex interplay of positive elements and a novel negative regulatory element.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668098     DOI: 10.1074/jbc.273.30.19130

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen-activated protein kinases and protein kinase Cdelta pathways in human adult articular chondrocytes.

Authors:  Hee-Jeong Im; Prasuna Muddasani; Viswanathan Natarajan; Thomas M Schmid; Joel A Block; Francesca Davis; Andre J van Wijnen; Richard F Loeser
Journal:  J Biol Chem       Date:  2007-02-20       Impact factor: 5.157

2.  Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing.

Authors:  Andreas Kurtz; Achim Aigner; Rafael H Cabal-Manzano; Robert E Butler; Dozier R Hood; Roy B Sessions; Frank Czubayko; Anton Wellstein
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

3.  Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma.

Authors:  Daniel Schulze; Philipp Plohmann; Sabrina Höbel; Achim Aigner
Journal:  Mol Cancer       Date:  2011-11-23       Impact factor: 27.401

4.  Acute Kidney Injury Sensitizes the Brain Vasculature to Ang II (Angiotensin II) Constriction via FGFBP1 (Fibroblast Growth Factor Binding Protein 1).

Authors:  Liang Zhao; Xiaoyun Cao; Lingli Li; Xiaohua Wang; Qin Wang; Shan Jiang; Chun Tang; Suhan Zhou; Nan Xu; Yu Cui; Weipeng Hu; Lingyan Fei; Zhihua Zheng; Limeng Chen; Marcel O Schmidt; Qichun Wei; Jingwei Zhao; Robert Labes; Andreas Patzak; Christopher S Wilcox; Xiaodong Fu; Anton Wellstein; En Yin Lai
Journal:  Hypertension       Date:  2020-10-12       Impact factor: 9.897

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.